P P Batchala1, T J E Muttikkal1, J H Donahue1, J T Patrie2, D Schiff3, C E Fadul3, E K Mrachek4, M-B Lopes4, R Jain5,6, S H Patel7. 1. From the Department of Radiology and Medical Imaging (P.P.B., T.J.E.M., J.H.D., S.H.P.). 2. Department of Public Health Sciences (J.T.P.). 3. Division of Neuro-Oncology (D.S., C.E.F.). 4. Department of Pathology (E.K.M., M.-B.L.), Divisions of Neuropathology and Molecular Diagnostics, University of Virginia Health System, Charlottesville, Virginia. 5. Departments of Radiology (R.J.). 6. Neurosurgery (R.J.), New York University School of Medicine, New York, New York. 7. From the Department of Radiology and Medical Imaging (P.P.B., T.J.E.M., J.H.D., S.H.P.) shp4k@virginia.edu.
Abstract
BACKGROUND AND PURPOSE: Isocitrate dehydrogenase (IDH)-mutant lower grade gliomas are classified as oligodendrogliomas or diffuse astrocytomas based on 1p/19q-codeletion status. We aimed to test and validate neuroradiologists' performances in predicting the codeletion status of IDH-mutant lower grade gliomas based on simple neuroimaging metrics. MATERIALS AND METHODS: One hundred two IDH-mutant lower grade gliomas with preoperative MR imaging and known 1p/19q status from The Cancer Genome Atlas composed a training dataset. Two neuroradiologists in consensus analyzed the training dataset for various imaging features: tumor texture, margins, cortical infiltration, T2-FLAIR mismatch, tumor cyst, T2* susceptibility, hydrocephalus, midline shift, maximum dimension, primary lobe, necrosis, enhancement, edema, and gliomatosis. Statistical analysis of the training data produced a multivariate classification model for codeletion prediction based on a subset of MR imaging features and patient age. To validate the classification model, 2 different independent neuroradiologists analyzed a separate cohort of 106 institutional IDH-mutant lower grade gliomas. RESULTS: Training dataset analysis produced a 2-step classification algorithm with 86.3% codeletion prediction accuracy, based on the following: 1) the presence of the T2-FLAIR mismatch sign, which was 100% predictive of noncodeleted lower grade gliomas, (n = 21); and 2) a logistic regression model based on texture, patient age, T2* susceptibility, primary lobe, and hydrocephalus. Independent validation of the classification algorithm rendered codeletion prediction accuracies of 81.1% and 79.2% in 2 independent readers. The metrics used in the algorithm were associated with moderate-substantial interreader agreement (κ = 0.56-0.79). CONCLUSIONS: We have validated a classification algorithm based on simple, reproducible neuroimaging metrics and patient age that demonstrates a moderate prediction accuracy of 1p/19q-codeletion status among IDH-mutant lower grade gliomas.
BACKGROUND AND PURPOSE:Isocitrate dehydrogenase (IDH)-mutant lower grade gliomas are classified as oligodendrogliomas or diffuse astrocytomas based on 1p/19q-codeletion status. We aimed to test and validate neuroradiologists' performances in predicting the codeletion status of IDH-mutant lower grade gliomas based on simple neuroimaging metrics. MATERIALS AND METHODS: One hundred two IDH-mutant lower grade gliomas with preoperative MR imaging and known 1p/19q status from The Cancer Genome Atlas composed a training dataset. Two neuroradiologists in consensus analyzed the training dataset for various imaging features: tumor texture, margins, cortical infiltration, T2-FLAIR mismatch, tumor cyst, T2* susceptibility, hydrocephalus, midline shift, maximum dimension, primary lobe, necrosis, enhancement, edema, and gliomatosis. Statistical analysis of the training data produced a multivariate classification model for codeletion prediction based on a subset of MR imaging features and patient age. To validate the classification model, 2 different independent neuroradiologists analyzed a separate cohort of 106 institutional IDH-mutant lower grade gliomas. RESULTS: Training dataset analysis produced a 2-step classification algorithm with 86.3% codeletion prediction accuracy, based on the following: 1) the presence of the T2-FLAIR mismatch sign, which was 100% predictive of noncodeleted lower grade gliomas, (n = 21); and 2) a logistic regression model based on texture, patient age, T2* susceptibility, primary lobe, and hydrocephalus. Independent validation of the classification algorithm rendered codeletion prediction accuracies of 81.1% and 79.2% in 2 independent readers. The metrics used in the algorithm were associated with moderate-substantial interreader agreement (κ = 0.56-0.79). CONCLUSIONS: We have validated a classification algorithm based on simple, reproducible neuroimaging metrics and patient age that demonstrates a moderate prediction accuracy of 1p/19q-codeletion status among IDH-mutant lower grade gliomas.
Authors: Sohil H Patel; Laila M Poisson; Daniel J Brat; Yueren Zhou; Lee Cooper; Matija Snuderl; Cheddhi Thomas; Ana M Franceschi; Brent Griffith; Adam E Flanders; John G Golfinos; Andrew S Chi; Rajan Jain Journal: Clin Cancer Res Date: 2017-07-27 Impact factor: 12.531
Authors: Hyun Jung Yoon; Kook Jin Ahn; Song Lee; Jin Hee Jang; Hyun Seok Choi; So Lyung Jung; Bum Soo Kim; Shin Soo Jeun; Yong Kil Hong Journal: Neuroradiology Date: 2017-05-26 Impact factor: 2.804
Authors: S Fellah; D Caudal; A M De Paula; P Dory-Lautrec; D Figarella-Branger; O Chinot; P Metellus; P J Cozzone; S Confort-Gouny; B Ghattas; V Callot; N Girard Journal: AJNR Am J Neuroradiol Date: 2012-12-06 Impact factor: 3.825
Authors: Joseph F Megyesi; Edward Kachur; Donald H Lee; Magdalena C Zlatescu; Rebecca A Betensky; Peter A Forsyth; Yoshifumi Okada; Hikaru Sasaki; Masahiro Mizoguchi; David N Louis; J Gregory Cairncross Journal: Clin Cancer Res Date: 2004-07-01 Impact factor: 12.531
Authors: P Darvishi; P P Batchala; J T Patrie; L M Poisson; M-B Lopes; R Jain; C E Fadul; D Schiff; S H Patel Journal: AJNR Am J Neuroradiol Date: 2020-04-23 Impact factor: 3.825
Authors: Arian Lasocki; Michael E Buckland; Katharine J Drummond; Heng Wei; Jing Xie; Michael Christie; Andrew Neal; Frank Gaillard Journal: Neuroradiology Date: 2022-05-24 Impact factor: 2.804
Authors: Rajan Jain; Derek R Johnson; Sohil H Patel; Mauricio Castillo; Marion Smits; Martin J van den Bent; Andrew S Chi; Daniel P Cahill Journal: Neuro Oncol Date: 2020-07-07 Impact factor: 12.300
Authors: Maike Kern; Timo A Auer; Uli Fehrenbach; Yasemin Tanyildizi; Thomas Picht; Martin Misch; Edzard Wiener Journal: Neuroradiol J Date: 2020-01-19
Authors: Sohil H Patel; Prem P Batchala; Thomas J Eluvathingal Muttikkal; Sergio S Ferrante; James T Patrie; Camilo E Fadul; David Schiff; M Beatriz Lopes; Rajan Jain Journal: J Neurooncol Date: 2021-03-04 Impact factor: 4.130
Authors: Evi J van Kempen; Max Post; Manoj Mannil; Benno Kusters; Mark Ter Laan; Frederick J A Meijer; Dylan J H A Henssen Journal: Cancers (Basel) Date: 2021-05-26 Impact factor: 6.639